AIDA proudly participated in the ESMO Gastrointestinal Cancers Congress and the Digestive Cancers Europe Masterclass, joining leading clinicians, researchers, and patient advocates to discuss the future of digestive cancer prevention.
At the event, the AIDA consortium showcased the development of its AI-powered diagnostic assistant designed to help clinicians identify precancerous gastric inflammation earlier and with greater precision. The tool aims to support personalised monitoring and guide treatment decisions that could prevent gastric cancer before it develops. These discussions underscored AIDA’s commitment to working alongside the European cancer community to deliver innovative, evidence-based solutions that improve patient outcomes.
